Cargando…

Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study

Background: Dimethyl fumarate (DMF) is a disease-modifying drug for relapsing-remitting multiple sclerosis. Among others, DMF impedes immune activation by shifting the balance between inflammatory and regulatory cell types and by inducing apoptosis-triggered lymphopenia. Although the decrease in lym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marastoni, Damiano, Buriani, Alessandro, Pisani, Anna Isabella, Crescenzo, Francesco, Zuco, Carmela, Fortinguerra, Stefano, Sorrenti, Vincenzo, Marenda, Bruno, Romualdi, Chiara, Magliozzi, Roberta, Monaco, Salvatore, Calabrese, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658905/ https://www.ncbi.nlm.nih.gov/pubmed/31379857 http://dx.doi.org/10.3389/fimmu.2019.01666

Ejemplares similares

CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2022)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
por: Magliozzi, Roberta, et al.
Publicado: (2020)

The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study
por: Crescenzo, Francesco, et al.
Publicado: (2021)

Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations
por: Sorrenti, Vincenzo, et al.
Publicado: (2016)

Deciphering the Role of Polyphenols in Sports Performance: From Nutritional Genomics to the Gut Microbiota toward Phytonutritional Epigenomics
por: Sorrenti, Vincenzo, et al.
Publicado: (2020)

Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
por: Crescenzo, Francesco, et al.
Publicado: (2020)

A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients
por: Pisani, Anna Isabella, et al.
Publicado: (2021)

Essential Oil Phytocomplex Activity, a Review with a Focus on Multivariate Analysis for a Network Pharmacology-Informed Phytogenomic Approach
por: Buriani, Alessandro, et al.
Publicado: (2020)

Pharmacogenomic Characterization in Bipolar Spectrum Disorders
por: Fortinguerra, Stefano, et al.
Publicado: (2019)

Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF
por: Pezzini, Francesco, et al.
Publicado: (2023)

Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways
por: Benedetti, Francesca, et al.
Publicado: (2020)

Understanding the Effects of Anesthesia on Cortical Electrophysiological Recordings: A Scoping Review
por: Sorrenti, Vincenzo, et al.
Publicado: (2021)

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2022)

Spirulina Microalgae and Brain Health: A Scoping Review of Experimental and Clinical Evidence
por: Sorrenti, Vincenzo, et al.
Publicado: (2021)

Patient outcomes influenced by reduced lymphocyte counts after dimethyl fumarate initiation
por: Wright, Katy, et al.
Publicado: (2017)

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021)

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2019)

Retrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H(2)+2CH(4)) versus H(2) threshold
por: Peron, Gregorio, et al.
Publicado: (2018)

Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols
por: Sorrenti, Vincenzo, et al.
Publicado: (2023)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Drug-Repurposing Strategy for Dimethyl Fumarate
por: Giunta, Salvatore, et al.
Publicado: (2023)

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
por: Sorrenti, Vincenzo, et al.
Publicado: (2022)

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
por: Sorrenti, Valeria, et al.
Publicado: (2020)

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort
por: Manni, Alessia, et al.
Publicado: (2019)

Dimethyl fumarate for ischemic stroke
por: Kunze, Reiner
Publicado: (2017)

Human Adenocarcinoma Cell Line Sensitivity to Essential Oil Phytocomplexes from Pistacia Species: a Multivariate Approach †
por: Buriani, Alessandro, et al.
Publicado: (2017)

Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
por: Yao, Yang, et al.
Publicado: (2016)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
por: Albrecht, Philipp, et al.
Publicado: (2012)

Dimethyl fumarate mitigates optic neuritis
por: Zyla, Katarzyna, et al.
Publicado: (2019)

Dimethyl fumarate transfer into human milk
por: Ciplea, Andrea I., et al.
Publicado: (2020)

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS: Patient management considerations
por: Fox, Robert J., et al.
Publicado: (2016)

Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
por: Casili, Giovanna, et al.
Publicado: (2020)

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
por: Calabrese, Massimiliano, et al.
Publicado: (2015)

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis
por: Magliozzi, R., et al.
Publicado: (2019)

Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
por: Diebold, Martin, et al.
Publicado: (2022)

Dimethyl fumarate for treating Papillon–Lefèvre syndrome
por: Al-Omair, Abdullah, et al.
Publicado: (2022)

The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
por: Manai, Federico, et al.
Publicado: (2022)

Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera(®) (Dimethyl Fumarate)
por: Lategan, Thomas W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgphs7fgh3fmp9322eusvbm0f9